Topic

Articles

Building on early achievements as a research scientist and drug inventor, Rod MacKenzie, today the leader of global product development at Pfizer—and latest HBA Honorable Mentor—has devoted much of his career to helping others succeed, including advancing efforts to break down gender barriers in pharma.


No Limits to Science, Or Self

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

Pharm Exec speaks to David Hysong, founder and Chief Executive Officer of SHEPHERD, whose mission, stated simply, is ”to make the drugs other companies won’t make to save lives others aren’t saving.”

Reaching for the Right to Live: David Hysong

Dr. Andrew (Drew) Otoo talks about how pharma employees can elevate their own value propositions.

Taking Ownership of Your Career Path: Drew Otoo, Merck

Agile Therapeutics' CEO Al Altomari talks about his decade of leadership at the company and the process of launching a new product during COVID-19.

Better Prepared for Unpredictability: Al Altomari, Agile Therapeutics

Dr. Matthias Schmidt talks about his new role leading the US subsidiary of Japan’s JCR Pharmaceuticals after a “far-from-easy” merger last year.

“In Rare Diseases, It’s Personal”: Dr. Matthias Schmidt, JCR USA

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com

Michael Bailey, CEO of AVEO Oncology, discusses how his ultimate leadership path in biotech—the setbacks and “long slog of ups and downs”—continues to shape a patient-focused mission on bridging product development and commercialization to advance drugs for unmet need in cancer.

Persevering for Patients

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Pratap Khedkar, managing principal for ZS’ global pharmaceuticals practice, talks to Pharm Exec about what companies need to focus on to achieve and optimize digital transformation in 2021 and beyond.

The Path to Meaningful Digital Transformation

Melissa Thompson, Alcon’s head of global corporate social responsibility, discusses her career commitment to CSR and how COVID-19 has impacted the organization’s efforts to improve access to eye care around the globe.

A Vision of a Fairer World

Sam Pearce, SVP, Head of Europe and International at Jazz Pharmaceuticals, talks about joining the company during a transformative period and how she is working to foster a bold and collaborative culture to expand Jazz’s footprint in Europe and beyond.

Sam Pearce: Joining the Jigsaw Pieces at Jazz

Mark Altmeyer, CEO of Arvelle, offers three recommendations for big pharma executives who are considering making the leap to startups.

Making the Leap from Big Pharma to Startups: Mark Altmeyer

Deeply shaped by the experiences of his parents and an early charge to help drive social change, Global Blood Therapeutics’ Ted Love comes at sickle cell disease from a place of caring and urges pharma to follow suit to bring justice to all.

Bound By Blood

Kevin Foust, Senior Director of Research & Early Development at Novartis Gene Therapies, talks to Pharm Exec about his involvement in the development of Zolgensma,  the first and only gene therapy approved to treat spinal muscular atrophy (SMA).

Hooked on Gene Therapy: Kevin Foust, Novartis

Samit Hirawat, chief medical officer at Bristol Myers Squibb, talks about his leading role in BMS’ $300M, five-year plan to expand its efforts in health equity and his career-long commitment to putting patients first.

Diversity of Thought in Action

Matt Ros, EVP, chief strategy and business officer of Epizyme, talks to Pharm Exec about his career in oncology and his role in transforming an epigenetics R&D company into a fully integrated commercial business.


Patients as the North Star

Dr. Husseini Manji talks to Pharm Exec about his new role as J&J's Head of Science for Minds and how he hopes to foster new ways to treat dementia and serious mental disorders and provide holistic mental care.

Advancing the Science for Minds: Dr. Husseini Manji, J&J

Angus Grant, Ph.D., Chief Business Executive of BeiGene, talks to Pharm Exec about his role and his vision for the company’s programs in oncology and beyond.

Partnering for the Future: Angus J. Grant, Chief Business Executive, BeiGene 

Anne E. White, president, Lilly Oncology, talks about how the lessons she learned from leading a startup helped her to speed Lilly’s drug development from target identification through successful launch  

Speed and Sensitivity

A glimpse inside the latest turn in Liz Barrett’s influential journey as an oncology executive—this time leaving the confines of big pharma to tackle the innovation void in treating urologic cancers.


Stepping Out in Oncology

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

EXUMA Biotech's Dr. Greg Frost talks about his work making CAR-T cell therapy readily accessible and affordable.

Executive Profiles